跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,708 条关于
“Comirnaty KP.2”
全部
64,708
临床试验
42,043
药物
7,391
机构
1,387
资讯
13,887
去年
EU Expands COVID-19 Vaccine Options: New Protein-Based Vaccines Join mRNA Offerings for 2024
2年前
Pfizer and BioNTech's Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive CHMP Opinion
去年
Pfizer and BioNTech Submit EMA Application for Updated COVID-19 Vaccine Targeting LP.8.1 Strain for 2025-2026 Season
2年前
FDA Approves Updated COVID-19 Vaccines Targeting Omicron Subvariants for 2024-2025 Season
2年前
Updated COVID-19 Vaccines Targeting JN.1 and KP.2 Variants Show Promise
去年
FDA Approves Updated COVID-19 Vaccines Targeting Omicron KP.2 Strain for 2024-25 Season
6个月前
Pfizer's Comirnaty Vaccine Transitions to Endemic Phase with Sustained European Market Presence
8个月前
KP.2 COVID-19 Vaccines Demonstrate Sustained 70% Effectiveness Over 12 Months in Major US Study
2个月前
Mirador Therapeutics Licenses KP-301, a Long-Acting Anti-C5a Antibody, Expanding into ANCA-Associated Vasculitis
去年
Arcturus/CSL COVID-19 Vaccine Shows Enhanced, Durable Immune Response Compared to Comirnaty
第 1 页,共 1389 页
上一页
下一页